Position in ACLX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$5,428,688
+$2,796,436 QoQ
Shares Held
47,280
+17.1% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $10,689,611,381 across 259 Biotechnology names. ACLX ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,331,554 | $2,380,752,123 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,180,631 | $1,684,842,735 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,783,394 | $920,941,572 | |
| 4 | INSM |
INSMED Inc
|
4,523,921 | $739,751,561 | |
| 5 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 6 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in ACLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,428,688 | 47,280 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,632,252 | 40,372 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $2,764,141 | 33,668 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,086,191 | 31,681 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,983,873 | 30,242 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,036,117 | 26,550 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,915,717 | 22,940 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,186,473 | 21,498 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,406,508 | 20,223 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,387,167 | 24,994 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $858,607 | 23,930 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $561,823 | 17,768 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $426,439 | 13,841 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $325,257 | 10,499 | Shares | Defined | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||